Cargando…
Latest impact of engineered human liver platforms on drug development
Drug-induced liver injury (DILI) is a leading cause of drug attrition, which is partly due to differences between preclinical animals and humans in metabolic pathways. Therefore, in vitro human liver models are utilized in biopharmaceutical practice to mitigate DILI risk and assess related mechanism...
Autores principales: | Monckton, Chase P., Brown, Grace E., Khetani, Salman R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIP Publishing LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286174/ https://www.ncbi.nlm.nih.gov/pubmed/34286173 http://dx.doi.org/10.1063/5.0051765 |
Ejemplares similares
-
A Cell Culture Platform to Maintain Long-term Phenotype of Primary Human Hepatocytes and Endothelial Cells
por: Ware, Brenton R., et al.
Publicado: (2017) -
Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
por: Lin, Christine, et al.
Publicado: (2016) -
Engineered matrix microenvironments reveal the heterogeneity of liver sinusoidal endothelial cell phenotypic responses
por: Brougham-Cook, Aidan, et al.
Publicado: (2022) -
Engineered Platforms for Maturing Pluripotent Stem Cell–Derived Liver Cells for Disease Modeling
por: Yuan, Yang, et al.
Publicado: (2023) -
Bioengineered Liver Models for Drug Testing and Cell Differentiation Studies
por: Underhill, Gregory H., et al.
Publicado: (2017)